A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers

NCT00504816 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2

Interventions

DRUG: GSK189075
DRUG: Brevicon

Sponsor

GlaxoSmithKline